Phase I-II

(Image: Getty/Kirtchanut)

New clinical trial firm formed following 3-company merger

By Melissa Fassbender

Three organizations have merged to form Apex Innovative Sciences, an independent clinical trial site operator focused on Phase I-IV studies for central nervous system indications and other therapeutic areas, including neurology, psychiatry, addiction,...

(Image: Getty/Tetiana Lazunova)

Parexel boosts RWD network via HealthVerity partnership

By Melissa Fassbender

Parexel increases its real world data network by more than 330m patients across 60 health care and consumer sources though a partnership with HealthVerity – which earlier this year raised $25m to advance its technology.

(Image: Getty/Oleksii Liskonih)

Clinerion adds 1m patients to network

By Melissa Fassbender

Hospital Angelina Caron of Campina Grande do Sul, Paraná has nearly one million patients, making it the largest hospital in Brazil to join Clinerion’s network.

(Image: Getty/utah778)

QPS moves forward with global expansion in response to client demand

By Melissa Fassbender

The CRO has opened a new clinic in response to demand for early-stage research, specifically for Alzheimer’s Disease, and expanded its footprint in India to conduct studies ‘at favorable pricing with faster timelines,’ say company executives.

Follow us

Product Innovations

Validating The Simoa Technology

Validating The Simoa Technology

Frontage is the first and only laboratory to validate Quanterix’ Simoa HD1 Analyzer for performing immunoassays. Most of the advanced instruments used...